News Focus
News Focus
icon url

lgonber

10/21/15 4:47 AM

#196154 RE: DewDiligence #196151

Definitely, not very exciting...
icon url

DewDiligence

11/16/15 5:34 PM

#197274 RE: DewDiligence #196151

COCP still touting its (DoA) HCV compound as “best in class”:

http://finance.yahoo.com/news/cocrystal-pharma-announces-filing-quarterly-221832746.html

Caveat emptor.